Acta Neurochirurgica

, Volume 129, Issue 3–4, pp 152–157 | Cite as

Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids

  • J. D. Pickard
  • V. Walker
  • L. Brandt
  • S. Zygmunt
  • J. Smythe
Clinical Articles


CSF eicosanoid levels are raised following subarachnoid haemorrhage but not sufficiently to be vasoactive per se within the cerebral circulation. Rebleeding and intraventricular haemorrhage are two factors associated with a worse outcome after aneurysmal SAH. We have examined the effects of these two factors on the CSF levels of TXB2 (TXA2 metabolite), PG 6-keto F (prostacyclin metabolite), PGF and PGE2 in 44 patients following subarachnoid haemorrhage. In 15 patients who had received no non-steroidal antiinflammatory agent or dexamethasone, intraventricular haemorrhage increased the median levels of all four eicosanoids in ventricular CSF by 2.1–5.1-fold. In 4 patients who rebled, the CSF median levels of all four eicosanoids were raised up to 250-fold over the normal range. These concentrations are just sufficient to have cerebrovascular and neuromodulatory effects.


Cerebrospinal fluid eicosanoids prostaglandins subarachnoid haemorrhage thromboxane 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Black P (1986) Hydrocephalus and vasospasm after subarachnoid haemorrhage from ruptured intracranial aneurysms. Neurosurgery 18: 12–16PubMedGoogle Scholar
  2. 2.
    Boullin DJ, Bunting S, Blaso WP, Hunt TM, Moncada S (1979) Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol 7: 139–147PubMedGoogle Scholar
  3. 3.
    Chan RC, Durity FA, Thompson GB, Nugent RA, Kendall M (1984) The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid haemorrhage in the rabbit. J Neurosurg 61: 1120–1128PubMedGoogle Scholar
  4. 4.
    Chehrazi BB, Giri S, Joy RM (1989) Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid haemorrhage. Stroke 20: 217–224PubMedGoogle Scholar
  5. 5.
    Clark FL, White RP (1989) Endothelium and cerebral vasospasm. Letter. J Neurosurg 70: 657–658Google Scholar
  6. 6.
    Chyatte D, Fode NC, Nichols DA, Sundt TM (1987) Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischaemia in patients at high risk for vasospasm after aneurysmal subarachnoid haemorrhage. Neurosurgery 21: 157–160PubMedGoogle Scholar
  7. 7.
    Cranston WI, Duff GW, Hellon RF, Mitchell D, Townsend Y (1976) Evidence that brain prostaglandin is not essential in fever. J Physiol 259: 239–249PubMedGoogle Scholar
  8. 8.
    Fukumori T, Tani E, Maeda Y, Sukenaga A (1983) Effects of prostacyclin and indomethacin on experimental cerebral vasospasm. J Neurosurg 59: 829–834PubMedGoogle Scholar
  9. 9.
    Gaetani P, Rodriguez y Baena R, Marzatico F (1993) Role of prostaglandins in delayed cerebral ischaemia after subarachnoid haemorrhage. Letter. Neurosurgery 32: 329PubMedGoogle Scholar
  10. 10.
    Hedqvist P, Wennmalm A (1971) Comparison of the effects of prostaglandin E1, E2, and F on the sympathetically stimulated rabbit heart. Acta Physiol Scand 83: 156–162PubMedGoogle Scholar
  11. 11.
    Maeda Y, Tani E, Miyamoto T (1981) Prostaglandin metabolism in experimental cerebral vasospasm. J Neurosurg 55: 779–785PubMedGoogle Scholar
  12. 12.
    Mendelow AD, Stockdill G, Steers AJ, Hayes J, Gillingham FJ (1982) Double-blind trial of aspirin in patients receiving tranexamic acid for SAH. Acta Neurochir (Wien) 62: 195–202Google Scholar
  13. 13.
    Mohr G, Ferguson G, Khar Met al (1983) Intraventricular haemorrhage from ruptured aneurysm. Retrospective analysis of 91 cases. J Neurosurg 58: 482–487PubMedGoogle Scholar
  14. 14.
    Nosko M, Schulz R, Weir B, Cook DA, Grace M (1988) Effects of vasospasm on levels of prostacyclin and thromboxane A2 in cerebral arteries of the monkey. Neurosurgery 22: 45–50PubMedGoogle Scholar
  15. 15.
    Okamoto S, Handa H, Toda N (1984) Role of intrinsic arachidonate metabolites in the vascular action of erythrocyte breakdown products. Stroke 15: 60–64PubMedGoogle Scholar
  16. 16.
    O'Neill P, Watton S, Foy PM, Shaw MDM (1991) Role of prostaglandins in delayed cerebral ischaemia after subarachnoid haemorrhage. Neurosurgery 30: 17–22Google Scholar
  17. 17.
    Pickard JD, Mackenzie ET (1973) Inhibition of prostaglandin synthesis and the response of baboon cerebral circulation to carbon dioxide. Nature (New Biol) 245: 187–188Google Scholar
  18. 18.
    Pickard JD, Walker V, Perry S, Smythe PJ, Eastwood S, Hunt R (1984) Arterial eicosanoid production following chronic exposure to a periarterial haematoma. J Neurol Neurosurg Psychiatry 47: 661–667PubMedGoogle Scholar
  19. 19.
    Pickard JD, Walker V, Vile J, Perry S, Smythe PJ, Hunt R (1987) Oral Nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid. J Neurol Neurosurg Psychiatry 50: 727–731PubMedGoogle Scholar
  20. 20.
    Pickard JD, Walker V, Newton H, Smythe PJ, Perry S (1990) Effect of hydrocephalus on prostaglandins and thromboxane B2 in ventricular cerebrospinal fluid. Neurosurgery 27: 943–945PubMedGoogle Scholar
  21. 21.
    Rodriguez y Baena R, Gaetani P, Foko G, Branzoli U, Paoletti P (1985) Cisternal and lumbar CSF concentration of arachidonate metabolites in vasospasm following subarachnoid haemorrhage from ruptured aneurysm. Surg Neurol 24: 428–432PubMedGoogle Scholar
  22. 22.
    Rogriguez y Baena R, Gaetami R, Grignani G, Pacchiarini L (1987) Effect of nimodipine on arachidonic acid metabolites after subarachnoid haemorrhage. Acta Neurol Scand 76: 267–271PubMedGoogle Scholar
  23. 23.
    Sasaki T, Marota S, Wakai S, Asano T, Sano K (1981) Evaluation of prostaglandin biosynthesis activity in canine basilar artery following subarachnoid injection of blood. J Neurosurg 55: 771–778PubMedGoogle Scholar
  24. 24.
    Seifert V, Stolke D, Kaever V, Dietz H (1987) Arachidonic acid metabolism following aneurysm rupture. Surg Neurol 27: 243–252PubMedGoogle Scholar
  25. 25.
    Suzuki S, Sobata E, Iwabuchi T (1981) Prevention of cerebral ischaemic symptoms in cerebral vasospasm with trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2. Neurosurgery 9: 679–685PubMedGoogle Scholar
  26. 26.
    Uski TK, Andersson KE (1984) Effects of prostanoids on isolated feline cerebral arteries. Acta Physiol Scand 120: 131–136PubMedGoogle Scholar
  27. 27.
    Vinge E, Brandt L, Ljunggren B, Andersson KE (1988) Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid haemorrhage. Stroke 19: 644–647PubMedGoogle Scholar
  28. 28.
    Walker V, Pickard JD (1985) Prostaglandins, thromboxane, leukotrienes, and the cerebral circulation in health and disease. Adv Tech Stand Neurosurg 12: 3–90PubMedGoogle Scholar
  29. 29.
    Walker V, Pickard JD, Smythe P, Eastwood S, Perry S (1983) Effects of subarachnoid haemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 46: 119–125PubMedGoogle Scholar
  30. 30.
    White RP, Hagen AA (1982) Cerebrovascular actions of prostaglandins. Pharmacol Ther 18: 303–331Google Scholar
  31. 31.
    White RP, Robertson JT (1983) Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm. Neurosurgery 12: 40–46PubMedGoogle Scholar
  32. 32.
    Wolfe LS, Coceani F (1979) The role of prostaglandins in the central nervous system. Ann Rev Physiol 41: 669–684Google Scholar
  33. 33.
    Zuccarello M, March JT, Schmitt G, Woodward J, Anderson DK (1989) Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid haemorrhage. J Neurosurg 71: 98–104PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • J. D. Pickard
    • 1
    • 2
  • V. Walker
    • 3
  • L. Brandt
    • 4
  • S. Zygmunt
    • 4
    • 5
  • J. Smythe
    • 3
  1. 1.Academic Neurosurgical UnitUniversity of CambridgeUK
  2. 2.Clinical Neurological Sciences GroupUniversity of SouthamptonUK
  3. 3.Department of Clinical BiochemistryUniversity of SouthamptonUK
  4. 4.University Department of NeurosurgeryLundSweden
  5. 5.Department of NeurosurgeryUniversity Hospital of Northern SwedenUmeaSweden

Personalised recommendations